Results 131 to 140 of about 15,215 (194)

Schizophrenia: Genetics, neurological mechanisms, and therapeutic approaches. [PDF]

open access: yesNeural Regen Res
Lim DXE   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

A Rab10–ACAP1–Arf6 GTPases cascade modulates M4 muscarinic acetylcholine receptor trafficking and signaling

Cellular and Molecular Life Sciences, 2023
Membrane trafficking processes regulate the G protein-coupled receptor activity. The muscarinic acetylcholine receptors (mAChRs) are highly pursued drug targets for neurological diseases, but the cellular machineries that control the trafficking of these receptors remain largely elusive.
Rongmei Xu   +6 more
openaire   +3 more sources

Development of Novel M4 Muscarinic Acetylcholine Receptor Antagonists for the Treatment of Movement Disorders

The FASEB Journal, 2022
Non‐selective antagonists of muscarinic acetylcholine receptors (mAChRs) that broadly inhibit all five mAChR subtypes provide an efficacious treatment for some movement disorders, including Parkinson’s disease and dystonia. Despite their efficacy in these and other central nervous system disorders, anti‐muscarinic therapy has ...
Jerri Rook   +8 more
openaire   +2 more sources

M4-muscarinic acetylcholine receptor into the pedunculopontine tegmental nucleus mediates respiratory modulation of conscious rats

Respiratory Physiology & Neurobiology, 2019
The pedunculopontine tegmental nucleus (PPTg) has been shown to have important functions relevant to the regulation of behavioral states and various motor control systems, including breathing control. The PPTg is considered an important nucleus in the mesopontine region with considerably cholinergic input to the ventral respiratory column. In addition,
Janayna D, Lima   +4 more
openaire   +3 more sources

Structural and Dynamic Mechanisms of Allostery at the M4 Muscarinic Acetylcholine Receptor

SSRN Electronic Journal, 2022
Ziva Vuckovic   +23 more
openaire   +2 more sources

Biased Profile of Xanomeline at the Recombinant Human M4 Muscarinic Acetylcholine Receptor.

ACS Chemical Neuroscience, 2022
Many Food and Drug Administration (FDA)-approved drugs are structural analogues of the endogenous (natural) ligands of G protein-coupled receptors (GPCRs).
J. Mcdonald   +8 more
semanticscholar   +1 more source

The M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) VU0453595 and M4 PAM VU0467154 Normalize Sleep‐Wake Architecture Deficits in Aged Mice

Alzheimer's & Dementia, 2022
Declining basal forebrain cholinergic integrity has been associated with disturbances in sleep‐wake architecture in Alzheimer’s Disease (AD). Acetylcholinesterase inhibitors (AChEIs) provide symptomatic treatment for the cognitive deficits in AD through ...
Jason K. Russell   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy